Menaka Bhor

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Neelima Denduluri, Debra A. Patt, Yunfei Wang et al. · Journal of the National Comprehensive Cancer Network · 2015 · 139 citations · Full text

Sickle cell disease complications: Prevalence and resource utilization

Nirmish Shah, Menaka Bhor, Lin Xie et al. · PLoS ONE · 2019 · 95 citations · Full text

Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer

Neelima Denduluri, Gary H. Lyman, Yunfei Wang et al. · Clinical Breast Cancer · 2018 · 81 citations · Full text

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease

Avery A. Rizio, Menaka Bhor, Xiaochen Lin et al. · Quality of Life Research · 2020 · 61 citations · Full text

Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

Nirmish Shah, Menaka Bhor, Lin Xie et al. · Health and Quality of Life Outcomes · 2019 · 60 citations · Full text